Ruben D Carrasco

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Chronic Lymphocytic Leukemia

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Science advances

Blood cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Pedro Pires Goulart Guimaraes, Christian G Figueroa-Espada, Rachel S Riley, Ningqiang Gong, Lulu Xue, Tomasz Sewastianik, Peter S Dennis, Claudia Loebel, Amanda Chung, Sarah J Shepherd, Rebecca M Haley, Alex G Hamilton, Rakan El-Mayta, Karin Wang, Robert S Langer, Daniel G Anderson, Ruben D Carrasco, Michael J Mitchell
In vivo bone marrow microenvironment siRNA delivery using lipid-polymer nanoparticles for multiple myeloma therapy. Proceedings of the National Academy of Sciences of the United States of America 120 (25) (2023)
Elisa Ten Hacken, Tomasz Sewastianik, Shanye Yin, Gabriela Brunsting Hoffmann, Michaela Gruber, M Kendell Clement, Livius Penter, Robert A Redd, Neil Ruthen, Sebastien Hergalant, Alanna Sholokhova, Geoffrey G Fell, Erin M Parry, Julien Broseus, Romain Guieze, Jennifer A Woyach, María Hernández-Sánchez, Kaitlyn Baranowski, Jackson Southard, Heather Joyal, Leah Billington, Fara Faye D Regis, Elizabeth Witten, Mohamed Uduman, Binyamin Asher Knisbacher, Shuqiang Li, Haoxiang Lyu, Tiziana Vaisitti, Silvia Deaglio, Giorgio Ga Inghirami, Pierre Feugier, Stephan Stilgenbauer, Eugen Tausch, Matthew S Davids, Gad A Getz, Kenneth J Livak, Ivana Bozic, Donna S Neuberg, Ruben D Carrasco, Catherine J Wu
In vivo modeling of CLL transformation to Richter's syndrome reveals convergent evolutionary paths and therapeutic vulnerabilities. Blood cancer discovery (2022)
Helen Tanton, Tomasz Sewastianik, Hyuk-Soo Seo, David Remillard, Roodolph St Pierre, Pratyusha Bala, Daulet Aitymbayev, Peter Dennis, Keith Adler, Ezekiel Geffken, Zoe Yeoh, Nicholas Vangos, Filip Garbicz, David A Scott, Nilay S Sethi, James E Bradner, Sirano Dhe-Paganon, Ruben D Carrasco
A novel β-catenin/BCL9 complex inhibitor blocks oncogenic Wnt signaling and disrupts cholesterol homeostasis in colorectal cancer. Science advances 8 (17) (2022)